1. 238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling. (9th November 2020) Authors: Jabado, Omar; Couto, Suzana; Blum, Jordan; Franken, Patrick; Souza, Patricia Coutinho de; Jure-Kunkel, Maria; Pencheva, Nora; Higgs, Brandon; Sasser, Kate; Fereshteh, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling. (10th December 2020) Authors: Jabado, Omar; Couto, Suzana; Blum, Jordan; Franken, Patrick; Souza, Patricia Coutinho de; Jure-Kunkel, Maria; Pencheva, Nora; Higgs, Brandon; Sasser, Kate; Fereshteh, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020) Authors: Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020) Authors: Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation. (31st December 2022) Authors: Muik, Alexander; Altintas, Isil; Gieseke, Friederike; Schoedel, Kristina B; Burm, Saskia M; Toker, Aras; Salcedo, Theodora W.; Verzijl, Dennis; Eisel, David; Grunwitz, Christian; Kranz, Lena M; Vormehr, Mathias; Satijn, David P.E.; Diken, Mustafa; Kreiter, Sebastian; Sasser, Kate; Ahmadi, Tahamta... Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. (1st January 2021) Authors: Naicker, Serika D; Feerick, Claire L; Lynch, Kevin; Swan, Dawn; McEllistrim, Cian; Henderson, Robert; Leonard, Niamh A; Treacy, Oliver; Natoni, Alessandro; Rigalou, Athina; Cabral, Joana; Chiu, Christopher; Sasser, Kate; Ritter, Thomas; O'Dwyer, Michael; Ryan, Aideen E Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin‐6. (4th June 2015) Authors: Chaturvedi, Shalini; Siegel, Derick; Wagner, Carrie L.; Park, Jaehong; van de Velde, Helgi; Vermeulen, Jessica; Fung, Man‐Cheong; Reddy, Manjula; Hall, Brett; Sasser, Kate Journal: British journal of clinical pharmacology Issue: Volume 80:Number 4(2015:Oct.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity. Issue 6 (10th June 2022) Authors: Muik, Alexander; Adams III, Homer C; Gieseke, Friederike; Altintas, Isil; Schoedel, Kristina B; Blum, Jordan M; Sänger, Bianca; Burm, Saskia M; Stanganello, Eliana; Verzijl, Dennis; Spires, Vanessa M; Vascotto, Fulvia; Toker, Aras; Quinkhardt, Juliane; Fereshteh, Mark; Diken, Mustafa; Satijn, Dav... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficient algorithms for covariate analysis with dynamic data using nonlinear mixed-effects model. (January 2021) Authors: Yuan, Min; Zhu, Zhi; Yang, Yaning; Zhao, Minghua; Sasser, Kate; Hamadeh, Hisham; Pinheiro, Jose; Xu, Xu Steven Journal: Statistical methods in medical research Issue: Volume 30:Number 1(2021) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Semimechanistic Physiologically‐Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B‐Cell Lymphomas. Issue 5 (27th September 2022) Authors: Li, Tommy; Hiemstra, Ida H.; Chiu, Christopher; Oliveri, Roberto S.; Elliott, Brian; DeMarco, Dena; Salcedo, Theodora; Egerod, Frederikke Lihme; Sasser, Kate; Ahmadi, Tahamtan; Gupta, Manish Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 5(2022) Page Start: 1108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗